Pat's Posse » Breast Cancer Medical Breakthroughs & News » What’s News In Breast Cancer

The biggest news for women who are at high risk to get breast cancer was recently presented at ASCO (American Society of Clinical Oncology) and published in New England Journal of Medicine in June 2011.

The Drug Exemestane (used in early and late breast cancer that is dependent on estrogen, about 70% of all cases) was tested in 4565 postmenopausal women with higher than usual risk to get breast cancer: 50% got 25 mg Exemestane (Aromasin) and 50% Placebo pill.

Exemestane significantly reduced invasive breast cancers in those postmenopausal women who were at moderately increased risk for breast cancer The relative risk reduction was an amazing 65 %. That is almost 2 of 3 cancers were avoided already after a median time of 35 months. At the same time, side effects were almost identical and statistically not different in these 2 groups.

You can read the full article at:

Exemestane for Breast-Cancer Prevention in Postmenopausal Women — NEJM

 by  Stefan Glück MD PhD FRCPC 
Sylvester Professor, Department of Medicine University of Miami
Sylvester Comprehensive Cancer Center Miami,FL


Pat's Posse » Breast Cancer Medical Breakthroughs & News » What’s News In Breast Cancer
Translate »